K. Rai

发表

Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity.

M. Grever, J. Byrd, J. Gribben, 2005, Leukemia research.

Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study

J. Byrd, J. Gribben, R. Larson, 2012, Leukemia & lymphoma.

Leukemic meningitis in B‐cell prolymphocytic leukemia. A clinical, pathologic, and ultrastructural case study and a review of the literature

K. Rai, M. Friedman, E. Valderrama, 1995, Cancer.

Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro.

P. Wang, K. Rai, R. Gartenhaus, 1996, Leukemia & lymphoma.

Guidelines for protocol studies in chronic lymphocytic leukemia

R. Silver, K. Rai, J. Holland, 1978, American journal of hematology.

Plasminogen‐dependent fibrinolytic activity in normal human lymphocytes: Diminished lymphocyte plasminogen activator in chronic lymphocytic leukemia

K. Rai, K. Rai, S. Zucker, 1985, American journal of hematology.

Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

M. Grever, A. Saven, B. Falini, 2022, Blood cancer journal.

Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses

T. Habermann, K. Rai, 2011, Leukemia & lymphoma.

Induction of T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo

J. Byrd, R. Larson, K. Rai, 2003 .

Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia

K. Rai, J. Barrientos, 2013, Leukemia & lymphoma.

Development of a distributed international patient data registry for hairy cell leukemia

M. Grever, A. Saven, P. Zinzani, 2022, Leukemia & lymphoma.